Keyword: Columbia University
A Columbia University team has developed a CRISPR alternative that uses a bacterial “jumping gene” to insert DNA sequences.
The $130 million is to be funneled over a 10-year period through a new company borne of the alliance known as Hudson Heights Innovations.
Tonix Pharmaceuticals is licensing a phase 2 treatment for cocaine intoxication from Columbia University.
A discovery of a mechanism that clears the toxic brain protein tau could lead to new ideas for treating Alzheimer's.
Sanofi VP Riccardo Perfetti has jumped to metabolic disease startup Applied Therapeutics to become its CMO as it moves into first-in-human trials.
The past week’s biotech news included insight into how ApoE4 raises Alzheimer’s risk and a peptide vaccine for broad flu protection.
The latest in biotech research includes a new way to grow human heart muscle and uncovering a genetic abnormality at the root of ALS and dementia.
Columbia University researchers have discovered a new link between the enzyme DPP4 and obesity—insight that could inspire new treatments for Type 2 diabetes.
Researchers discovered a new mechanism that regulates the protein titin, which plays a key role in helping muscles function—especially in the heart.
The past week ushered in discoveries related to high cholesterol, acute myeloid leukemia and age-related memory loss.